Clinical Trials - Phase II
Filter News
Found 29,770 articles
-
Pharmion Corporation Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
6/4/2007
-
Regeneron Pharmaceuticals, Inc. and Sanofi-Aventis (France) Release: Results of VEGF Trap (Aflibercept) Highlighted at American Society of Clinical Oncology 2007 Annual Meeting
6/4/2007
-
Genta Incorporated Phase 2 Clinical Results of Ganite(R) Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at American Society of Clinical Oncology
6/4/2007
-
Roche Release: Xeloda(R) Plus Avastin(R) Combination Delays Disease Progression in Women with Advanced Breast Cancer
6/4/2007
-
Abraxis BioScience, Inc.: ABRAXANE Demonstrates Longer Progression-Free Survival versus Taxotere in the Treatment of First-Line Metastatic Breast Cancer
6/4/2007
-
Eli Lilly and Company Release: Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer
6/4/2007
-
Sanofi-Aventis (France) and Regeneron Pharmaceuticals, Inc. Results of VEGF Trap (Aflibercept) Highlighted at American Society of Clinical Oncology 2007 Annual Meeting
6/4/2007
-
Introgen Therapeutics, Inc. Announces Positive Phase 2 Clinical Trial Results with INGN 225 Immunotherapy in Patients with Small Cell Lung Cancer
6/4/2007
-
YM BioSciences Cleared to Initiate Clinical trial of Nimotuzumab in Colorectal Cancer
6/4/2007
-
AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at American Society of Clinical Oncology Meeting
6/4/2007
-
Ariad Pharmaceuticals, Inc. Presents Positive Efficacy Data On AP23573, Novel mTOR Inhibitor, in Phase 2 Metastatic Endometrial Cancer Trial
6/4/2007
-
Genentech, Inc. Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
6/4/2007
-
Micromet Final Data from a Phase 2 Trial Presented at American Society of Clinical Oncology Specifies Dose-dependent Activity of Adecatumumab (MT201)
6/4/2007
-
Danube Pharmaceuticals, Inc. Taps Aptuit for Integrated Phase II Drug Development Project
6/4/2007
-
Poniard Pharmaceuticals, Inc. Announces Results of Picoplatin Phase 2 Trial That Confirm and Extend Survival Benefit in Small Cell Lung Cancer
6/4/2007
-
Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II trial of Cloretazine(R) (VNP40101M) in Patients with Relapsed or Refractory Small Cell Lung Cancer
6/4/2007
-
Introgen Therapeutics, Inc. Reports Updated Phase 2 ADVEXIN(R) Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
6/4/2007
-
Pharmion Corporation and MethylGene Report Preliminary Data for MGCD0103 at the 43rd American Society of Clinical Oncology Annual Meeting
6/4/2007
-
Transave, Inc. Reports Promising Data From a Phase I/II Trial of SLIT(TM) Cisplatin in Patients With Osteosarcoma Metastatic to the Lung
6/4/2007
-
Oxford BioMedica PLC and Sanofi-Aventis (France) Report new TroVax(R) Phase II Trial Results in Renal Cancer
6/4/2007